Generali Asset Management’s Elevance Health ELV Stock Holding History

Generali Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.93M	Sell	20,393 -22,833	-53%	-$9.11M	0.14%	142
2026 Q2	$16.7M	Buy	43,226 +24,350	+129%	+$9.03M	0.3%	77
2026 Q1	$5.53M	Buy	18,876 +241	+1%	+$79.2K	0.12%	174
2025 Q4	$6.53M	Buy	18,635 +676	+4%	+$228K	0.13%	144
2025 Q3	$5.8M	Sell	17,959 -4,518	-20%	-$1.41M	0.12%	157
2025 Q2	$8.74M	Sell	22,477 -2,790	-11%	-$1.12M	0.2%	107
2025 Q1	$11M	Buy	+25,267	New	+$10.1M	0.27%	82

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

ACR Alpine Capital Research St. Louis, Missouri $7.35B AUM 21.37% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

High Ground Investment Management London, United Kingdom $1.3B AUM 17.7% 1-Year Est. Return

Generali Asset Management's ELV Position: Q3 2026 in Review

Generali Asset Management reduced its Elevance Health (ELV) stake by 53% in Q3 2026, selling an estimated $9.11M and leaving 20,393 shares worth $7.93M. The position accounts for 0.14% of the portfolio, ranked #142.

Generali Asset Management first reported a position in ELV in Q1 2025 and has held it in 7 quarters since. The position peaked at $16.7M in Q2 2026. 866 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Generali Asset Management held 20,393 shares of Elevance Health worth $7.93M as of Q3 2026.
Generali Asset Management sold 22,833 Elevance Health shares in Q3 2026, an estimated $9.11M.
Elevance Health made up 0.14% of Generali Asset Management's portfolio in Q3 2026, its #142 holding.
Generali Asset Management first reported a position in Elevance Health in Q1 2025 and has held it in 7 quarters since.
Generali Asset Management's Elevance Health position peaked at $16.7M in Q2 2026.
866 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Generali Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.